Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Acta oncologica

• Publication date

  2017-11-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/0284186X.2017.1400688PMID 29145765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

  2017cited by this paper
• Role of primary surgery in the treatment of advanced oropharyngeal cancer

  2016cited by this paper
• Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines

  2016cited by this paper
• Laryngeal cancer in Finland: A 5‐year follow‐up study of 366 patients

  2016cited by this paper
• Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

  2016cited by this paper
• Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.

  2015cited by this paper
• The role of surgery for HPV-associated head and neck cancer.

  2015cited by this paper
• HPV-Positive Oropharyngeal Carcinoma

  2015cited by this paper
• Staging and treatment of oropharyngeal cancer in the human papillomavirus era

  2014cited by this paper
• Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009

  2014cited by this paper
• J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

  2014cited by this paper
• An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center

  2013cited by this paper
• Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.

  2013cited by this paper
• Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.

  2013cited by this paper
• Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

  2013cited by this paper
• Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

  2013cited by this paper
• Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.

  2012cited by this paper
• Predicting recurrence after radiotherapy in head and neck cancer.

  2012cited by this paper
• Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer

  2012cited by this paper
• Up‐front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer

  2012cited by this paper
• The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.

  2011cited by this paper
• Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin.

  2011influential reference
• Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

  2011influential reference
• Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy

  2010cited by this paper
• Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006

  2010cited by this paper
• Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications

  2010cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?

  2009cited by this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009influential reference
• Outcomes of patients with tonsillar carcinoma treated with post‐tonsillectomy radiation therapy

  2009cited by this paper
• Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults.

  2009cited by this paper
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

  2008cited by this paper
• Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

  2008cited by this paper
• Changes in Treatment of Advanced Oropharyngeal Cancer, 1985–2001

  2007cited by this paper
• Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis

  2007cited by this paper
• A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

  2007cited by this paper
• Oropharyngeal carcinoma and its treatment in Finland between 1995–1999: a nationwide study

  2006cited by this paper
• High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

  2006cited by this paper
• Squamous cell carcinoma of the oropharynx

  2002cited by this paper
• Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

  2000cited by this paper
• Serological pattern of influenza virus strains isolated in Canada from 1948 to 1951.

  1953cited by this paper

• Republication de : Sex and survival in oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis

  2026cites this paper
• Sex and survival in oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis.

  2025cites this paper
• Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update.

  2025cites this paper
• Occupation and tongue cancer in Nordic countries

  2024cites this paper
• Timing and frequency of oropharyngeal squamous cell carcinoma recurrences after treatment with curative intent

  2023cites this paper
• Costs of oropharyngeal squamous cell cancer treatment in Finland

  2023influential citation
• Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact

  2020cites this paper
• Factors influencing patient and health care delays in Oropharyngeal Cancer

  2020cites this paper
• Comparing serum protein levels can aid in differentiating HPV-negative and -positive oropharyngeal squamous cell carcinoma patients

  2020cites this paper
• Long‐term Quality of Life After Treatment of Oropharyngeal Squamous Cell Carcinoma

  2020cites this paper
• High-Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non-Indigenous and Indigenous Populations: A Systematic Review

  2020cites this paper
• Upfront radical neck dissection in patients cN2-3

  2019cites this paper
• Evaluation of prognostic markers for oropharyngeal carcinoma using tissue microarray

  2019cites this paper
• Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact Outcome

  2019cites this paper
• Disección radical de cuello inicial en pacientes cN2-3

  2019cites this paper
• The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus–positive and –negative oropharyngeal squamous cell carcinoma

  2019cites this paper
• Women with cervical cancer precursor lesions: a high-risk group for human papillomavirus (HPV)-related oropharyngeal cancer?

  2019cites this paper
• Management of clinically N0 neck in oropharyngeal carcinoma

  2019cites this paper
• Advances in Transoral Approaches for Laryngeal Cancer

  2019cites this paper
• High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer

  2019cites this paper
• In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.

  2019cites this paper
• Transoral Robotic Surgery in the Nordic Countries: Current Status and Perspectives

  2018cites this paper
• University of Southern Denmark Transoral Robotic Surgery in the Nordic Countries Current Status and Perspectives

  2018cites this paper
• De‐escalation of post‐treatment surveillance in oropharyngeal cancer

  2018cites this paper